A pan-immunotherapy signature to predict CD8+ T cell expansion in the tumor (IMAGE)

Tokyo University of Science

A pan-immunotherapy signature to predict CD8+ T cell expansion in the tumor

Caption

Scientists from Tokyo University of Science, Japan, have identified a set of ‘signature’ genes that can determine whether cancer-fighting T cells will multiply or stall within the tumor. Their findings provide a powerful pan-immunotherapy biomarker for treatment monitoring and pave the way for next-generation immunodynamic therapies.

Credit

Dr. Satoshi Ueha from Tokyo University of Science, Japan

Usage Restrictions

Cannot be used without permission.

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.